Goldman Sachs Optimistic About Regenxbio’s Gene Therapy Pipeline, Sees Over 160% Upside
Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
ASML Remains Top Pick In EU Semicaps, Analyst Highlights Key Role In AI Infrastructure And Multiple Expansion
BofA Securities analyst reiterated Buy rating on ASML Holding N.V. with a raised price target, reflecting higher confidence in demand for EUV tools and higher gross margin. ASML remains top pick in EU Semicaps due to its irreplicable role in AI infrastructure buildout.
Lyft Competing In Lock-step With Uber Technologies: Analysts Eye ‘Multiple Shots’ On Goal For Growth
Lyft's FY27 targets reveal anticipated growth, prompting mixed analyst reactions, with upgrades, downgrades, and price forecast adjustments.
What 12 Analyst Ratings Have To Say About Hewlett Packard
In the last three months, 12 analysts have published ratings on Hewlett Packard (NYSE:HPE), offering a diverse range…
Assessing Blueprint Medicines: Insights From 16 Financial Analysts
In the preceding three months, 16 analysts have released ratings for Blueprint Medicines (NASDAQ:BPMC), presenting a wide array…
Where Robinhood Markets Stands With Analysts
Throughout the last three months, 21 analysts have evaluated Robinhood Markets (NASDAQ:HOOD), offering a diverse set of opinions…
Navigating 5 Analyst Ratings For Open Lending
Across the recent three months, 5 analysts have shared their insights on Open Lending (NASDAQ:LPRO), expressing a variety…
A Glimpse Into The Expert Outlook On SoFi Techs Through 8 Analysts
During the last three months, 8 analysts shared their evaluations of SoFi Techs (NASDAQ:SOFI), revealing diverse outlooks from…
Navigating 13 Analyst Ratings For Las Vegas Sands
Analysts’ ratings for Las Vegas Sands (NYSE:LVS) over the last quarter vary from bullish to bearish, as provided…
Skechers Stock Set For Growth As Footwear Trends Remain Solid: BofA Analyst
Bank of America analyst Christopher Nardone has upgraded Skechers USA to Buy, raising the price target from $71 to $87. Nardone cites an improving wholesale environment, solid footwear trends, and conservative 2H sales guidance.